作者:Yongxin Han、André Giroux、John Colucci、Christopher I. Bayly、Daniel J. Mckay、Sophie Roy、Steve Xanthoudakis、John Vaillancourt、Dita M. Rasper、John Tam、Paul Tawa、Donald W. Nicholson、Robert J. Zamboni
DOI:10.1016/j.bmcl.2004.12.006
日期:2005.2
The iterative process for the discovery of a series of pyrazinone mono-amides as potent, selective and reversible non-peptide caspase-3 inhibitors (e.g., M826 and M867) is reported. These compounds display potent anti apoptotic activities in a number of cell based systems in vitro as well as in several animal models in vivo. (C) 2004 Elsevier Ltd. All rights reserved.